openPR Logo
Press release

Rise in Incidence Rate of Venous Thromboembolism is Fueling the Venous Thromboembolism Market

06-28-2017 01:52 PM CET | Health & Medicine

Press release from: Transparency Market Research

Rise in Incidence Rate of Venous Thromboembolism is Fueling

Venous thromboembolism (VTE) is the formation of blood clots inside the blood vessel. These clots restrict blood flow through the circulatory system. It is classified into two type’s deep vein thrombosis and pulmonary embolism. Formation of blood clot in a deep vein (generally in the leg) is called deep vein thrombosis. The formed deep vein thrombosis clot break off and travels to the lungs, called as pulmonary embolism. Pulmonary embolism is a serious complication from deep vein thrombosis. It occurs in almost one-third of patients suffering from deep vein thrombosis. Venous thromboembolism can occur at any age; however, it is common in adults aged 60 and above.

People who are overweight, older, whose blood is thicker than normal or suffer from some other diseases such as autoimmune disorders (rheumatoid arthritis, lupus, etc.) or cancer are at a higher risk of venous thromboembolism. Hospitalization due to major trauma (fractures or immobilization) or surgery increases the risk for venous thromboembolism. Up to 60% of venous thromboembolism cases occur during or after hospitalization. Venous thromboembolism equally affects men and women. Globally, venous thromboembolism is the third most common cardiovascular disease and leading cause of death and disability.

Obtain Report Details @ http://www.transparencymarketresearch.com/venous-thromboembolism-market.html

Venous thromboembolism is a life-threatening medical condition that requires immediate medical treatment. Treatment primarily focuses on breaking the clots and preventing further formation of clots. Treatment includes blood thinning agents such as anticoagulants (such as unfractionated and low molecular weight heparin as well as warfarin), mechanical devices (compression stockings), and thrombolytic therapy (tissue plasminogen activator).

The venous thromboembolism market is expected to expand in the near future, led by the development of novel oral anticoagulants (NOACs) to overcome the limitation of current treatment options and provide improved patient of care. NOACs are classified into direct thrombin inhibitors (argatroban, dabigatran), which inhibit factor IIa (thrombin), and factor Xa inhibitors (rivaroxaban, edoxaban, apixaban). NOACs offer major pharmacological benefits over current vitamin K antagonists (heparin or warfarin). These include rapid onset and offset of action, predictable pharmacokinetics, and less drug interactions, which eliminate the need for regular coagulation monitoring associated with conventional anticoagulant therapy.

Increase in government expenditure, rise in incidence rate of venous thromboembolism, growth in patient awareness about treatment, and high unmet needs of current treatment options are fueling the venous thromboembolism market. However, complex pathophysiology of the disease, high cost of treatment, and side effects associated with it act as key restraints for the venous thromboembolism market.

The venous thromboembolism market can be segmented based on disease type, product type, and geography. In terms of disease type, the venous thromboembolism market can be segregated into deep vein thrombosis and pulmonary embolism. The pulmonary embolism segment is estimated to expand more than the deep vein thrombosis segment, as pulmonary embolism is the third most common cause for hospital related deaths. Based on product type, the venous thromboembolism market can be divided into anticoagulants, medical devices, and others. In anticoagulant segment, NOAC’s market is expected to grow because it eliminates the need for regular coagulation monitoring, overcoming the major limitation of current standard of care.

Make an Enquiry @ http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=25934

In terms of geography, the venous thromboembolism market can be classified into North America, Latin America, Europe, Asia Pacific, and Middle East & Africa. North America dominates the venous thromboembolism market, followed by Europe, due to the higher incidence and prevalence rate than that in Asia Pacific and Middle East & Africa, increase in demand for advance treatment, and rise in geriatric population in the region. Asia Pacific is an emerging market for venous thromboembolism due to the developing healthcare infrastructure and rising government expenditure in the healthcare industry. However, affordability issues, lack of proper treatment, and poor patient education are factors restraining the venous thromboembolism market in such as Middle East & Africa and Latin America.

Major players operating in the venous thromboembolism market include Bristol-Myers Squibb Company, Sanofi S.A., Pfizer, Inc., Daiichi Sankyo Co. Ltd., Johnson & Johnson, AbbVie Inc., Merck & Co., and Astellas Pharma Inc.

About Us

Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Contact Us

Transparency Market Research
State Tower,
90 State Street, Suite 700
Albany, NY 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Rise in Incidence Rate of Venous Thromboembolism is Fueling the Venous Thromboembolism Market here

News-ID: 600201 • Views: 106

More Releases from Transparency Market Research

Subsea Well Access System Market In-depth qualitative insights, historical data, …
Global Subsea Well Access System Market: Overview The global subsea well access system market is primarily driven by plummeting production from the oil and gas reserves together with ageing offshore fields. A quick shift toward subsea regions is the emerging trend in oil and gas production sector, marking an important divergence from the usual methods of production. Some of the subsea environment exists in most unexplored and extremely remote parts of
Nicotinic Acid Market Size, Share, Growth, Trends, and Forecast 2027
Overview The research report provides valuable insights into demand drivers, geographical outlook, and competitive landscape of the Nicotinic Acid Market for the 2019-2027 forecast period. Further, it throws light on restraints as well discusses opportunities at length that are likely to come to the fore over the forecast period. The analysis thus provided helps Market stakeholders with business planning and to gauge scope of expansion in the Nicotinic Acid Market over
1 – Decene Market Growth Analysis, Share, Demand By Regions 2027
Overview The research report provides valuable insights into demand drivers, geographical outlook, and competitive landscape of the 1 – Decene Market for the 2019-2027 forecast period. Further, it throws light on restraints as well discusses opportunities at length that are likely to come to the fore over the forecast period. The analysis thus provided helps Market stakeholders with business planning and to gauge scope of expansion in the 1 – Decene
Steep Slope Roofing Materials Market Analysis, Size, Share, Growth, Trends, and …
Overview The research report provides valuable insights into demand drivers, geographical outlook, and competitive landscape of the 1 – Decene Market for the 2019-2027 forecast period. Further, it throws light on restraints as well discusses opportunities at length that are likely to come to the fore over the forecast period. The analysis thus provided helps Market stakeholders with business planning and to gauge scope of expansion in the 1 – Decene

All 5 Releases


More Releases for Venous

[PDF] Venous Blood Collection Devices Market 2018 - Healthcare 2018
Venous blood collection devices are vessels used for collection, sampling, and testing blood samples. These devices are easy to handle, provide mechanical protection as well as protection from contamination and radiation. Moreover, these blood collection devices offer the exact filling volume. The global venous blood collection devices market is driven by the increasing diagnostics and screening for numerous diseases, increasing health awareness leading to growing demand for blood collection devices for
Global Central Venous Catheters Sales Market Research Report 2018
This report studies the global Central Venous Catheters market status and forecast, categorizes the global Central Venous Catheters market size (value & volume) by key players, type, application, and region. This report focuses on the top players in North America, Europe, China, Japan, Southeast Asia India and Other regions (Middle East & Africa, Central & South America). A central venous catheter, also called a central line, is a long, thin, flexible
Forecast and Analysis on Venous Stents Market by MarketResearchReports.biz
MarketResearchReports.Biz adds “Global Venous Stents Market Share, Size, Trends and Forecast Market Research Report” reports to its database. This report provides a strategic analysis of the Venous Stents and the growth estimates for the forecasted period. This report studies the Venous Stents market status and outlook of global and United States, from angles of players, regions, product types and end industries; this report analyzes the top players in global and United
Venous Stents Market to Witness Widespread Expansion During 2025
Transparency Market Research (TMR) observes that the competitive landscape in The Global Venous Stents Market is intensifying. The rise of venous disorders amongst the global population has urged several key players to develop better products. Key players such as Boston Scientific Corporation, C. R. Bard, Inc., Jotec GmBH, are Veniti, Inc. are making major investments in conducting clinical trials to understand the implications of their products. Such efforts are expected
Venous Thromboembolism Market - Global Industry Analysis 2025
According to the International Society on Thrombosis and Haemostasis, Inc., venous thromboembolism (VTE) is a leading cause of death and disability worldwide. Approximately 10 million cases of venous thromboembolism occur annually. VTE refers to the formation of blood clots in vein. If the clot is in deep vein (usually leg), it is called as deep vein thrombosis, while a clot in lungs is termed as pulmonary embolism. Request to download and
Central Venous Catheter Market Segmentation and Competitor Analysis Report
A central venous catheter, also called as central line, is a long, thin, flexible tube which is used to give medicines, fluids, nutrients and even blood products, usually for a long period of time. It is usually inserted in the arm or in the chest through the skin and supplies the needful into a large vein that can help circulate in the body. The catheter is placed in a large